The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Aug. 18, 2017
Applicant:
H&a Pharmachem Co., Ltd, Gyeonggi-do, KR;
Inventors:
Jong Hyeon Lee, Gyeonggi-do, KR;
Se Hee Cho, Seoul, KR;
Young Rong Woo, Gangwon-Do, KR;
Young Ah Park, Gangwon-Do, KR;
Hong Geun Ji, Gyeonggi-do, KR;
Assignee:
H&A PHARMACHEM CO., LTD., Gyeonggi-Do, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/06 (2006.01); A61K 8/34 (2006.01); A61K 8/68 (2006.01); A61K 8/97 (2017.01); A61K 8/64 (2006.01); A61K 8/67 (2006.01); A61K 8/73 (2006.01); A61K 8/9789 (2017.01); A61K 8/9794 (2017.01); A61K 8/92 (2006.01); A61K 8/27 (2006.01); A61K 8/368 (2006.01); A61K 8/46 (2006.01); A61K 8/55 (2006.01); A61K 8/60 (2006.01); A61K 8/63 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/194 (2006.01); A61K 31/573 (2006.01); A61K 47/14 (2017.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61P 29/00 (2006.01); A61P 5/24 (2006.01); A61P 17/02 (2006.01); A61P 17/00 (2006.01); A61P 17/14 (2006.01); A61P 31/04 (2006.01); A61P 3/02 (2006.01); A61Q 19/00 (2006.01); A61Q 7/00 (2006.01); A61Q 17/04 (2006.01); A61Q 19/02 (2006.01);
U.S. Cl.
CPC ...
A61K 8/06 (2013.01); A61K 8/27 (2013.01); A61K 8/34 (2013.01); A61K 8/345 (2013.01); A61K 8/368 (2013.01); A61K 8/463 (2013.01); A61K 8/55 (2013.01); A61K 8/553 (2013.01); A61K 8/60 (2013.01); A61K 8/63 (2013.01); A61K 8/64 (2013.01); A61K 8/67 (2013.01); A61K 8/68 (2013.01); A61K 8/73 (2013.01); A61K 8/735 (2013.01); A61K 8/92 (2013.01); A61K 8/922 (2013.01); A61K 8/97 (2013.01); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 9/1075 (2013.01); A61K 31/194 (2013.01); A61K 31/573 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61P 3/02 (2018.01); A61P 5/24 (2018.01); A61P 17/00 (2018.01); A61P 17/02 (2018.01); A61P 17/14 (2018.01); A61P 29/00 (2018.01); A61P 31/04 (2018.01); A61Q 7/00 (2013.01); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01); A61Q 19/007 (2013.01); A61Q 19/02 (2013.01); A61K 2800/413 (2013.01);
Abstract
The present invention relates to: a composition for transdermal delivery, comprising 1) a nanoemulsion comprising an active ingredient, saturated lecithin, phytosteryl/behenyl/octyldodecyl lauroyl glutamate, a polyol, and water, and 2) a modified layered double hydroxide; and a preparation method therefor.